{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T13:54:40Z","timestamp":1794146080098,"version":"4.8.0"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"33","license":[{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8,15]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>SMARCA4-deficient undifferentiated uterine sarcoma (SDUS) is a rare, sporadic malignant tumor of mesenchymal origin of the uterus, which has highly aggressive and poor prognosis. In this case, we described a malignant tumor formed in the uterus occurring in a SMARCA4 deletion type and discussed its clinical characteristics, differential diagnosis, treatment and related literature analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A 61-year-old patient underwent diagnostic scraping at a local hospital for irregular vaginal bleeding for 2 months. The postoperative pathology suggested endometrial malignancy. A subsequent pelvic ultrasound at our hospital revealed that the endometrium was not clear, and a slightly hypoechoic mass of 7\u2005+\u2005cm was seen in the uterine cavity. This mass had an irregular shape and unclear demarcation from the myometrium. Furthermore, the presence of abundant blood flow signals was detected in and around the uterine cavity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>The patient was ultimately diagnosed with stage IB SDUS by postoperative routine pathology and immunohistochemistry.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>The patient underwent a single-port laparoscopic total hysterectomy, bilateral adnexectomy and pelvic lymph node dissection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>The patient has undergone 3 cycles of postoperative platinum-based chemotherapy combined with docetaxel and epirubicin, and during the follow-up period, the patient remained in good overall condition without evidence of disease progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>SDUS is a rare uterine sarcoma which cannot be underestimated and warrants careful clinical follow-up and histological evaluation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000043828","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T19:01:07Z","timestamp":1755543667000},"page":"e43828","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["SMARCA4-deficient undifferentiated uterine sarcoma: A case report and literature review"],"prefix":"10.1097","volume":"104","author":[{"given":"Yu","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Gynecology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4465-3211","authenticated-orcid":false,"given":"Ying","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Gynecology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Gynecology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0670-2233","authenticated-orcid":false,"given":"Xing","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Gynecology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5180-9234","authenticated-orcid":false,"given":"Huihua","family":"Dai","sequence":"additional","affiliation":[{"name":"Department of Gynecology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260911","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.humpath.2022.03.009","article-title":"The value of SOX2 in the differential diagnosis of SMARCA4 (BRG1)-deficient uterine neoplasms.","volume":"124","author":"Zheng","year":"2022","journal-title":"Hum Pathol"},{"key":"R2-20260911","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1053\/j.semdp.2020.08.003","article-title":"SWI\/SNF-deficient malignancies of the female genital tract.","volume":"38","author":"McCluggage","year":"2021","journal-title":"Semin Diagn Pathol"},{"key":"R3-20260911","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1038\/s41379-018-0049-z","article-title":"SMARCA4-deficient undifferentiated uterine sarcoma (malignant rhabdoid tumor of the uterus): a clinicopathologic entity distinct from undifferentiated carcinoma.","volume":"31","author":"Kolin","year":"2018","journal-title":"Modern Pathol"},{"key":"R4-20260911","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/PAS.0000000000001375","article-title":"SMARCA4-deficient uterine sarcoma and undifferentiated endometrial carcinoma are distinct clinicopathologic entities.","volume":"44","author":"Kolin","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"R5-20260911","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1038\/s41379-019-0303-z","article-title":"SMARCA4 inactivation defines a subset of undifferentiated uterine sarcomas with rhabdoid and small cell features and germline mutation association.","volume":"32","author":"Lin","year":"2019","journal-title":"Mod Pathol"},{"key":"R6-20260911","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/modpathol.2015.155","article-title":"Loss of switch\/sucrose non-fermenting complex protein expression is associated with dedifferentiation in endometrial carcinomas.","volume":"29","author":"Karnezis","year":"2016","journal-title":"Mod Pathol"},{"key":"R7-20260911","doi-asserted-by":"crossref","first-page":"100788","DOI":"10.1016\/j.gore.2021.100788","article-title":"Unfolding the rarity of SMARCA4 deficient uterine sarcoma (SDUS): a case report.","volume":"37","author":"Baa","year":"2021","journal-title":"Gynecol Oncol Rep"},{"key":"R8-20260911","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1158\/1078-0432.CCR-19-3797","article-title":"Small-cell carcinoma of the ovary, hypercalcemic type-genetics, new treatment targets, and current management guidelines.","volume":"26","author":"Tischkowitz","year":"2020","journal-title":"Clin Cancer Res"},{"key":"R9-20260911","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.3390\/cancers15153794","article-title":"Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT): patient characteristics, treatment, and outcome \u2013 a systematic review.","volume":"15","author":"Wens","year":"2023","journal-title":"Cancers (Basel)"},{"key":"R10-20260911","doi-asserted-by":"crossref","first-page":"100728","DOI":"10.1016\/j.adro.2021.100728","article-title":"Notable response of SMARCA4-deficient undifferentiated uterine sarcoma to palliative radiation therapy.","volume":"6","author":"Kurokawa","year":"2021","journal-title":"Adv Radiat Oncol"},{"key":"R11-20260911","first-page":"761","article-title":"Research advances in the different molecular subtypes of uterine mesenchymal tumours.","volume":"52","author":"Cai","year":"2023","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"R12-20260911","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1158\/1535-7163.MCT-21-0433","article-title":"SMARCA4: implications of an altered chromatin-remodeling gene for cancer development and therapy.","volume":"20","author":"Mardinian","year":"2021","journal-title":"Mol Cancer Ther"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000043828","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:00:34Z","timestamp":1789153234000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000043828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,15]]},"references-count":12,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000043828","relation":{},"ISSN":["1536-5964","0025-7974"],"issn-type":[{"value":"1536-5964","type":"electronic"},{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,15]]},"assertion":[{"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}